The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Condition(s):HIV InfectionsLast Updated:August 14, 2008Terminated
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:August 14, 2008Terminated
Condition(s):HIV InfectionsLast Updated:May 9, 2023Recruiting
Condition(s):HIV/AIDSLast Updated:September 28, 2023Active, not recruiting
Condition(s):HIV InfectionsLast Updated:April 5, 2012Completed
Condition(s):HIV InfectionsLast Updated:November 1, 2021Completed
Condition(s):HIV-Associated Lipodystrophy SyndromeLast Updated:May 7, 2010Completed
Condition(s):Alpha 1-Antitrypsin DeficiencyLast Updated:August 19, 2014Completed
Condition(s):HIVLast Updated:May 22, 2018Unknown status
Condition(s):HIV-1 Infection; Treatment Resistant Disorders; ViremiaLast Updated:October 12, 2015Terminated
Condition(s):HIV InfectionsLast Updated:December 4, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.